Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Point-of-Care Testing
2012 Standout
Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery
2007
Methods for evaluation of platelet function
2009 StandoutNobel
John Snow's legacy: epidemiology without borders
2013 StandoutNobel
Tranexamic acid in aortic valve replacement
2001
Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial☆
2009
Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials
2009
Cost-Effectiveness Analysis of Administering Tranexamic Acid to Bleeding Trauma Patients Using Evidence from the CRASH-2 Trial
2011
Tranexamic Acid
2012
Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: A prospective, randomized, double-blind, placebo-controlled study
2002
Perioperative Management of Antithrombotic Therapy
2012 Standout
Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass
2004
A Double-Blind, Placebo-Controlled Trial of Epsilon-Aminocaproic Acid for Reducing Blood Loss in Coronary Artery Bypass Grafting Surgery
2005
Effect of tranexamic acid on blood loss reduction after cardiopulmonary bypass
2001
Single-Dose Tranexamic Acid Reduces Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Until Surgery
2003
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list
2013
Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials
2005
The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis
2008
Tranexamic Acid and Aprotinin in Primary Cardiac Operations: An Analysis of 220 Cardiac Surgical Patients Treated with Tranexamic Acid or Aprotinin
2008
Tranexamic acid does not correct the haemostatic impairment caused by hydroxyethyl starch (200 kDa/0.5) after cardiac surgery
2006
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Does Tranexamic Acid Reduce Blood Loss in Off-Pump Coronary Artery Bypass?
2007
Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques
2004
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
A propensity score case‐control comparison of aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgery
2006
Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery
2004
Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease
2017 Standout
Tranexamic acid reduces bleeding and the need for blood transfusion in primary myocardial revascularization
2002
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis
2012
The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery
2005
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial
2003
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients
2013
Tranexamic Acid and Primary Coronary Artery Bypass Surgery: A Prospective Study
2007
Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study
2001
Reduction of Blood Loss with Tranexamic Acid in Primary Total Hip Replacement Surgery
2007
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Reduction of Haemorrhagic Complications during Mechanically Assisted Circulation with the Use of a Multi-System Anticoagulation Protocol
1995
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting
2006
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of M Cossolini being referenced
Split and whole liver transplantation outcomes: A comparative cohort study
2006
Assisted circulation for myocardial recovery after repair of congenital heart disease
1991
Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: Effects on perioperative bleeding and allogeneic transfusions
2000
Hemostatic effects of aprotinin, tranexamic acid and ϵ-aminocaproic acid in primary cardiac surgery
1999
Tranexamic Acid Administration after Cardiac Surgery
2001